Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples